Ziopharm Oncology buy exploration
Start price
22.04.16
/
50%
€7.12
Target price
19.07.16
€10.10
Performance (%)
-43.45%
End price
19.07.16
€4.03
Summary
This prediction ended on 19.07.16 with a price of €4.03. Massive losses of -43.45% were the result for the BUY prediction by exploration. exploration has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ziopharm Oncology | - | - | - | - |
| iShares Core DAX® | 0.336% | 4.366% | 21.868% | 63.911% |
| iShares Nasdaq 100 | 0.541% | 3.170% | 7.017% | 108.934% |
| iShares Nikkei 225® | 4.048% | 6.727% | 22.855% | 57.329% |
| iShares S&P 500 | 0.795% | 3.281% | 4.698% | 67.940% |
Comments by exploration for this prediction
In the thread Ziopharm Oncology diskutieren
Ziopharm: Biotechwerte werden wieder interessant
langfristig werden auch Biotechwerte wieder interessant.
(Stop Loss Kurs erreicht)


